ETF overview
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Current price
102.78 USD-0.67%
Close 21 Oct 2026Interval
BenchmarksFund facts
- Expense ratio
- 0.37%
- Fund assets
- 1.56B USD (all share classes)
- Issuer
- iShares
- Inception date
- May 1, 2006
- Number of holdings
- 53
Breakdown
Holdings (53)
| Name | Ticker | Weight |
|---|---|---|
| ELI LILLY | LLY | 25.24% |
| JOHNSON & JOHNSON | JNJ | 21.50% |
| ZOETIS INC CLASS A | ZTS | 4.85% |
| PFIZER | PFE | 4.81% |
| VIATRIS | VTRS | 4.65% |
| MERCK & CO INC | MRK | 4.46% |
| ROYALTY PHARMA PLC CLASS A | RPRX | 4.46% |
| BRISTOL MYERS SQUIBB | BMY | 4.26% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | 3.09% |
| ELANCO ANIMAL HEALTH | ELAN | 2.61% |
| and 40 more | ||
Similar ETFs
- VanEck Pharmaceutical ETFPPH · Overlap 46% · Expense ratio 0.36%
- First Trust Nasdaq Pharmaceuticals ETFFTXH · Overlap 40% · Expense ratio 0.60%
- State Street SPDR S&P Pharmaceuticals ETFXPH · Overlap 40% · Expense ratio 0.35%
- Portfolio Building Block World Pharma and Biotech Index ETFPBPH · Overlap 38% · Expense ratio 0.13%
- Invesco Pharmaceuticals ETFPJP · Overlap 37% · Expense ratio 0.58%
- iShares U.S. Healthcare ETFIYH · Overlap 35% · Expense ratio 0.37%
- State Street Health Care Select Sector SPDR ETFXLV · Overlap 35% · Expense ratio 0.08%
- Vanguard Health Care ETFVHT · Overlap 32% · Expense ratio 0.09%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
Benchmarks
Fund facts
- Expense ratio
- 0.37%
- Fund assets
- 1.56B USD (all share classes)
- Issuer
- iShares
- Inception date
- May 1, 2006
- Number of holdings
- 53
Breakdown
Holdings (53)
| Name | Ticker | Weight |
|---|---|---|
| ELI LILLY | LLY | 25.24% |
| JOHNSON & JOHNSON | JNJ | 21.50% |
| ZOETIS INC CLASS A | ZTS | 4.85% |
| PFIZER | PFE | 4.81% |
| VIATRIS | VTRS | 4.65% |
| MERCK & CO INC | MRK | 4.46% |
| ROYALTY PHARMA PLC CLASS A | RPRX | 4.46% |
| BRISTOL MYERS SQUIBB | BMY | 4.26% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | 3.09% |
| ELANCO ANIMAL HEALTH | ELAN | 2.61% |
| and 40 more | ||
ETF overview
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
- VanEck Pharmaceutical ETFPPH · Overlap 46% · Expense ratio 0.36%
- First Trust Nasdaq Pharmaceuticals ETFFTXH · Overlap 40% · Expense ratio 0.60%
- State Street SPDR S&P Pharmaceuticals ETFXPH · Overlap 40% · Expense ratio 0.35%
- Portfolio Building Block World Pharma and Biotech Index ETFPBPH · Overlap 38% · Expense ratio 0.13%
- Invesco Pharmaceuticals ETFPJP · Overlap 37% · Expense ratio 0.58%
- iShares U.S. Healthcare ETFIYH · Overlap 35% · Expense ratio 0.37%
- State Street Health Care Select Sector SPDR ETFXLV · Overlap 35% · Expense ratio 0.08%
- Vanguard Health Care ETFVHT · Overlap 32% · Expense ratio 0.09%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free